- Home
- AZN vs WFC Comparison
AZN vs WFC Comparison
Compare AZN & WFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AZN | WFC |
|---|---|---|
| Founded | 1992 | 1852 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.7B | 290.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AZN | WFC |
|---|---|---|
| Price | $208.86 | $88.68 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 16 |
| Target Price | N/A | ★ $97.37 |
| AVG Volume (30 Days) | 1.6M | ★ 15.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 1.51% | ★ 2.02% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.84 | $11.53 |
| Revenue Next Year | $6.16 | $4.57 |
| P/E Ratio | $32.35 | ★ $14.21 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $122.26 | $58.42 |
| 52 Week High | $212.19 | $97.76 |
Technical Indicators
Market Signals| Indicator | AZN | WFC |
|---|---|---|
| Relative Strength Index (RSI) | 87.12 | 45.40 |
| Support Level | $187.06 | $85.09 |
| Resistance Level | $193.97 | $95.09 |
| Average True Range (ATR) | 4.23 | 2.89 |
| MACD | 4.29 | -0.40 |
| Stochastic Oscillator | 96.80 | 35.90 |
Price Performance
Historical ComparisonAbout AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
About WFC Wells Fargo & Company
Wells Fargo is one of the largest banks in the United States, with approximately $2.1 trillion in balance-sheet assets. The company has four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the US market.